NOREGEN Trademark

Trademark Overview

On Monday, September 19, 2022, a trademark application was filed for NOREGEN with the United States Patent and Trademark Office. The USPTO has given the NOREGEN trademark a serial number of 97597343. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, August 27, 2024. This trademark is owned by Caeregen Therapeutics, LLC. The NOREGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurosensory-related diseases
noregen

General Information

Serial Number97597343
Word MarkNOREGEN
Filing DateMonday, September 19, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurosensory-related diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCaeregen Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRochester, MI 48309
Party NameCaeregen Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRochester, MI 48309

Trademark Events

Event DateEvent Description
Thursday, September 22, 2022NEW APPLICATION ENTERED
Tuesday, October 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 28, 2023ASSIGNED TO EXAMINER
Wednesday, June 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 26, 2024SOU EXTENSION 1 FILED
Monday, April 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 1, 2024PETITION TO REVIVE-GRANTED
Monday, July 1, 2024NOTICE OF REVIVAL - E-MAILED
Monday, July 1, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, July 1, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, July 30, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 30, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 30, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 30, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 28, 2024SOU EXTENSION 1 GRANTED
Wednesday, August 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

noregen related diseases neurosensory treatment preparations pharmaceutical